Daily Archives: June 27, 2017

Cautionary tale on ‘hot’ stocks and confident bets

Innate Immunotherapeutics is a small Australian biotech company who’s main drug is an investigational treatment for multiple sclerosis.  New York House Rep Chris Collins is a board member and was Innate’s largest shareholder with a position valued at over $45 … Continue reading

Posted in Main Page | Comments Off on Cautionary tale on ‘hot’ stocks and confident bets

Faber notes grounds for ‘epic’ market decline ahead

As fresh-faced CNBC hosts come and go, a few guests have decades of real life market experience. Fewer still are independents free to call conditions as they seem them, unconstrained by their corporate sales targets for proprietary financial products and … Continue reading

Posted in Main Page | Comments Off on Faber notes grounds for ‘epic’ market decline ahead